Polycystic Ovarian Syndrome
Study Results from Columbia University Provide New Insights into Polycystic Ovarian Syndrome
Published in Women's Health Weekly, September 15th, 2011
2011 SEP 15 -- According to the authors of recent research published in the Journal of Clinical Endocrinology & Metabolism, "The dopamine/dopamine receptor 2 (D2/Drd2) pathway modulates vascular endothelial growth factor (VEGF)-dependent vascular permeability and angiogenesis in the ovary. Deregulation of the VEGF/VEGF receptor (VEGFR)-2 pathway leading to increased risk of ovarian hyperstimulation syndrome has been described in the ovary of patients suffering from polycystic ovarian syndrome (PCOS)."
"The objective of the study was to ascertain whether deregulation of the VEGF/VEGFR-2 might a least be partially due to abnormalities of the D2/Drd2...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Findings from IARC in Breast Cancer Reported - Breast Cancer
Indiana University Details Research in Breast Cancer - Premature Ovarian Failure
Investigators at Azienda Ospedaliera University Zero in on Premature Ovarian Failure - Breast Cancer
New Breast Cancer Data Have Been Reported by E. Simou and Co-Authors - Breast Cancer
New Breast Cancer Data Have Been Reported by Researchers at Mayo Clinic - Breast Cancer
New Breast Cancer Study Findings Reported from University Hospital - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
